A milestone day for clinical trial innovation.
We’re announcing the first real-time clinical trials, where @US_FDA can see data signals and endpoints in real time. A quick explainer:
Do you have a technology recommended for early use in the NHS that needs further evidence for wider adoption?
Apply now to our Invention for Innovation (i4i) Product Development Awards (PDA) NICE early use funding opportunity. Supporting technologies recommended for early use in the NHS by @NICEComms early use assessment.
⏰ Deadline: 27 May, 1pm
Apply now ➡️ https://t.co/Ta5nISsxSp
Healthtech developers with a NICE early use recommendation – new dedicated NIHR funding is now available to help generate the evidence needed for wider NHS adoption⤵️
Thousands of people at higher risk of developing cancer due to inherited faulty genes will be regularly checked by the NHS, thanks to a first-of-its-kind national genetics programme.
Read more ⬇️
https://t.co/81XNFdw7XO
The ‘trust gap’ is the most overlooked opportunity in healthcare investment right now. Our new report, State of Health AI 2026, breaks down why that gap is starting to close.
Discover:
🔹 Health Tech 1.0 vs 2.0 and the trust reset
🔹 Why AI now captures 55% of health tech funding
🔹7 predictions that will shape health AI in 2026 and beyond
🔹 The 4 pillars of true X Factor companies
Read State of Health AI 2026: https://t.co/f1vB13nhFB
Priscilla Chan and Mark Zuckerberg on Curing All Disease
We sat down with Dr. Priscilla Chan and Mark Zuckerberg, co-founders of the Chan Zuckerberg Initiative, to discuss their ambitious plan to cure, prevent, and manage all disease by the end of the century.
CZI’s Biohub aims to generate vast biological datasets to train new frontier AI models to guide scientists in the lab, creating a feedback loop to accelerate the pace of basic science and take us towards a world without disease.
00:00 Introduction
03:42 Building tools to accelerate scientific discovery
07:03 Biohub = Frontier Biology + Frontier AI
13:32 "Most diseases should be thought of as rare diseases”
15:39 Inspiration: building a periodic table for biology
19:27 Why virtual cells?
21:17 The Biohub master plan
33:36 The importance of interface design in democratizing scientific discovery
35:34 How Biohub encourages cross-functional collaboration
40:38 Looking ahead: the broader impact of AI on biotech
@bhorowitz@vintweeta@eriktorenberg
⚕️ The Healthcare AI Adoption Index⚕️
We partnered with AWS and Bain & Company to learn from 400+ healthcare buyers on what’s driving AI experimentation, from proof-of-concept to production, and how this will impact startups and innovation partners.
Dive into the research from @SofiaGuerraR and @stephenkraus: https://t.co/JM118c4O7T
Today, the @US_FDA issued the draft guidance, Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations, including considerations to support marketing submissions for AI-enabled devices: https://t.co/Y0AEUhVXvu
Today, we issued draft guidance to provide recommendations on the use of artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product’s safety, effectiveness or quality. https://t.co/QvvieDTzkg
📢We've published a new statement of intent for AI at NICE.
The statement outlines our approach to:
🔹providing guidance on AI methods to support evidence generation
🔹evaluating AI-based tech for NHS use
🔹exploring AI tool use in our internal processes
https://t.co/QE0CwdTL4d
First to propose, first to deliver.
The world’s first comprehensive artificial intelligence rules enter into force today.
Thanks to the AI Act, European citizens and businesses can now safely and confidently seize the opportunities offered by AI ↓
#AIAct#AIinEurope
Fertility-focused period-tracking app Flo Health raised a $200 million Series C.
The funding values the startup at more than $1 billion post-money, which, per the company, makes it the first “purely digital” femtech app to become a unicorn.
Read more: https://t.co/g8m1vXuojQ
H1 2024 funding numbers are in—with $5.7B deployed across 266 #digitalhealth startup raises, 2024 could outperform 2023 if #investment pace holds. Read our H1 2024 funding recap to digest the past 6 months of funding, exits, acquisitions, and more: https://t.co/jgNPeMkBDr
Digital health has been hit hard by the ongoing venture downturn. With funding and deals plummeting, we break down what's happening in the market and what to expect next: https://t.co/UCyqGeaCm3
In 2023, U.S. #digitalhealth startups raised $10.7B—the lowest year of investment since 2019. But downrounds, shutdowns + acquisitions didn’t spike. To learn why not + understand what 2023's funding patterns mean for 2024, read our 2023 funding recap: https://t.co/7zlNPzEGVJ
The historic first day of the #AISafetySummit saw:
🌍 28 countries and the EU announcing the Bletchley Declaration
🇰🇷 🇫🇷 2 more AI Summits by South Korea and France
🖥️ The UK announcing 2 cutting-edge supercomputers
Hear from @michelledonelan as day 2 of the Summit begins...👇
We created a new Digital Health Advisory Committee to help us explore the complex, scientific & technical issues related to digital health technologies, such as artificial intelligence/machine learning, augmented reality, virtual reality, digital therapeutics, wearables & remote patient monitoring. https://t.co/BXVTJc6feq
Those interested in serving on the committee may apply at: https://t.co/uH9ZkgFahA
WHO recognizes the potential of #ArtificialIntelligence (AI) in enhancing #HealthForAll. AI can help:
✅ Predict diseases
✅ Personalize treatment
✅ Health workers interpret medical images
✅ Educate patients
✅ Ensure that patients take their medicines on schedule
More in our latest publication on #AI for health 👉https://t.co/UADn0T1PlU
📢UK patients set to have faster access to innovative medical technologies via new pathway 📢
Through the pathway partners will offer support to successful applicants
Submissions for the pilot phase open 18/09/23 & close 29/10/23
Info & how to apply ➡️ https://t.co/jYhO2ffl9F